Arrhythmias & electrophysiology

Symptom Preoccupation in Atrial Fibrillation and its Association With Quality of Life: A Cross-Sectional Study

JACC AdvPublished cross-sectional study

Authors' conclusion

Symptom preoccupation is common in AF patients. Behavioral interventions that specifically target symptom preoccupation could potentially increase QoL, reduce health care use, and improve symptom experience in AF.

Study context

Population
Swedish atrial fibrillation (AF) patientsSwedish AF patients who completed an online survey
Participants
409 patients
Exposure
Association of symptom preoccupation (Cardiac Anxiety Questionnaire) and other psychological variables with AF-specific quality of life (QoL), general disability, symptom severity and health care use
Outcome
Prevalence of symptom preoccupation
Methodological detailsonline survey
  • Online survey

Main finding

As reported in the abstract

Symptom preoccupation present in respondents

37%

Females

59%

Males

23%

Observational data: associations, not effects.

Further findings

Association of symptom preoccupation with health care use

Incidence rate ratio (95% CI)P value
Symptom preoccupationStrongest association1.67 (1.28–2.19)P < 0.001

Association with general disability

β (95% CI)P value
DepressionMost strongly associated0.45 (0.32–0.58)P < 0.001
Symptom preoccupationSignificant but weaker association0.31 (0.19–0.43)P < 0.001
OutcomeEstimateP value
Association of symptom preoccupation with impaired QoLStrongest associationregression coefficient [β] −0.51 (95% CI −0.61 to −0.41)P < 0.001
Association of symptom preoccupation with symptom severityStrongest associationβ 0.39 (95% CI 0.27–0.50)P < 0.001

Original publication

Symptom Preoccupation in Atrial Fibrillation and its Association With Quality of Life: A Cross-Sectional Study. JACC Adv. Published 8 August 2025. doi:10.1016/j.jacadv.2025.102058

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.